Walgreens Boots Alliance (NASDAQ:WBA) has been reviewed by 6 analysts with mixed opinions, ranging from bullish to bearish. The average 12-month price target is now $26.67, down 11.1% from the previous $30.00. Analysts from firms including HSBC, JP Morgan, RBC Capital, Truist Securities, and Mizuho have adjusted their ratings and price targets, reflecting their views on the company's performance and market conditions. Walgreens is a major retail pharmacy chain in the U.S., with significant market presence and recent positive revenue growth, but concerns arise from its high debt-to-equity ratio.